Iconovo Slims Down As It Focuses On Commercialization

Reduces Costs Via Job Cuts As It Moves Towards Marketing Inhaled Products

As its need for development resources declines, Iconovo is cutting staff to save money as it moves to the commercialization stage for its portfolio of off-patent inhaled products.

Iconovo is cutting development roles as it focuses on commercialization (Shutterstock)

More from Strategy

More from Value Added Medicines